Authors

Stephen Huber
Latest Article

Basal cell carcinoma treatments on the horizon

In this pipeline report, Dermatology Times presents insights into Hh pathway inhibitors currently in phase 2 and phase 3 for the treatment of basal cell carcinoma. 

Mollie MacCormack, M.D.
Latest Article

Tips to minimize audit stress

Audits can be an unfortunate reality of practicing medicine. This expert explains the four main types of audits and offers tips to minimize audit stress.

Gina M. Caputo, D.O.
Latest Article

How stress impacts chronic skin conditions

Recognizing the role of stress in skin disease can allow dermatologists to empower their patients to pursue any and all avenues for managing their disease.

Adam Raff, M.D., Ph.D.
Latest Article

The case for hackathons in dermatology

A central goal of Hacking Dermatology, one of the first ever dermatology-focused hackathons, is to build a community of people interested in collaborating to improve the current standards of care for patients with skin disease. Learn how to get involved in this article.

Alex Costa, M.Sc.
Latest Article

The case for hackathons in dermatology

A central goal of Hacking Dermatology, one of the first ever dermatology-focused hackathons, is to build a community of people interested in collaborating to improve the current standards of care for patients with skin disease. Learn how to get involved in this article.

Laura Duerksen, M.B.A.
Latest Article

The case for hackathons in dermatology

A central goal of Hacking Dermatology, one of the first ever dermatology-focused hackathons, is to build a community of people interested in collaborating to improve the current standards of care for patients with skin disease. Learn how to get involved in this article.

Lawrence Chukwudi Nwabudike, M.D., MBBS, MRCP (U.K.), PhD
Latest Article

An introduction to homeopathy for the dermatologist

Lawrence Chukwudi Nwabudike, M.D., MBBS, MRCP (U.K.), PhD delves into what dermatologists need to know about homeopathy.

Zoe Diana Draelos, M.D.
Latest Article

The role of ’biotics in skincare

Zoe Diana Draelos, M.D, discusses prebiotic, probiotic and postbiotic skincare products and their role in normalizing the skin microbiome.

Anna Chacon, M.D.
Latest Article

Laser Device Purchases Are Guided by Multiple Factors

Determine whether a laser device is a good investment for a specific practice and, if so, how to choose the right piece of equipment.

Joel Cohen, M.D.
Latest Article

The case for physical sunscreen

Joel Cohen, M.D., shares his response to recent findings regarding the safety of chemical sunscreen and discusses why patients should consider using physical sunscreens.

Dean Celia
Latest Article

Dean Celia reflects on 40th anniversary of Dermatology Times

Dean Celia, our original managing editor, reflects the beginning of Dermatology Times and the medical editors, Dr. Ronald Wheeland and Dr. Norman Levine,  who ensured the publication focused on the key industry developments that mattered most to practicing dermatologists.

Lilit Garibyan, M.D.
Latest Article

Creative initiative involves clinicians in innovation

Drs. Lilit Garibyan, Steve Xu and Kachiu C. Lee highlight a grassroots initiative that encourages physicians to become more involved in innovation in dermatology.

Kachiu C. Lee, M.D.
Latest Article

From Consultation to Transformation: Kachiu Lee, MD, MPH, FAAD, Emphasizes Strategic Aesthetics at PDPA 2025

Kachiu Lee, MD, MPH, FAAD, shares insights on aesthetic dermatology at the 2025 PDPA Keystone, emphasizing trust and communication over technology for optimal results.

Cheryl Krader
Latest Article

IL-17 potential therapeutic target for pustular psoriasis

Researchers performed a systematic review of available reports on the therapeutic benefit of interleukin (IL)-17/T-helper 17 (Th17) axis inhibitors in patients with generalized pustular psoriasis (GPP). Read what they discovered in this article.

Art Papier, M.D., FAAD
Latest Article

AI: It’s not dermatologist vs. machine

In this month's Innovation article, Steve Xu, M.D., FAAD, highlights a company and innovator who are using artificial intelligence to augment physician decision-making, not replace it. ƒ

Mildred López Piñeiro, M.D.
Latest Article

Ultrasound technology may be useful treatment for rosacea

Drs. López and Kaufman discuss two new studies that examine the use of ultrasound technology as a new modality for treatment of erythematotelangiectatic and refractory rosacea.

Usama Syed
Latest Article

DTC compounded medications: A treatment option for a system in need?

How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.

Raymond Miller, J.D.
Latest Article

DTC compounded medications: A treatment option for a system in need?

How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.

Brandon Kirsch, M.D., J.D.
Latest Article

DTC compounded medications: A treatment option for a system in need?

How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.

Hans Hofland, Ph.D.
Latest Article

Spotlight on Dermira and the QBREXZA story

Hans Hofland, Ph.D, and Dr. Steve Xu shine a spotlight on Dermira and its novel topical medicine indicated for primary axillary hyperhidrosis in patients 9 years of age and older.

Todd Petersen
Latest Article

A successful ownership transition

Todd Petersen, CEO of VitalSkin Dermatology, discusses the last part of your transition journey – ensuring a smooth, successful transition for you, your team and your patients.

Carol Soutor, M.D.
Latest Article

Mind-body therapies effective for skin disorders

Carol Soutor, M.D., writes about efficacy and safety of mind-body therapies for the treatment of various skin conditions. 

Sponsored by Galderma
Brian Kim, M.D., MTR
Latest Article

Advances in Itch: Brian S. Kim, MD, Shares Insights and Treatment Tips

Kim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.

Duke Leahey
Latest Article

Nuogen Pharma: Innovation in the fight against itch

Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.

Bobby Buka, M.D., J.D.
Latest Article

Practicing dermatology in the time of COVID-19

Read one New York physician's insights on practice survival and patient care during the pandemic.

Denise Myshko
Latest Article

CVS Removes Biosimilars From Drug List

One notable change: CVS Caremark has removed the Humira biosimilar Amjevita and now prefers Hyrimoz and an unbranded biosimilar.

Patricia Richey, MD, FAAD
Latest Article

The Role of Laser Treatments in Preventing Skin Cancer

Patricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.

Karishma Daftary, BA
Latest Article

Think Globally to Combat Acne

Take a world tour of the global game-changing advances and home-grown success strategies dermatologists in the United States and abroad are using to tackle the challenges of acne.

Lauren Joszt
Latest Article

Atopic Dermatitis Remains Controlled Even After Reduction of Dupilumab Dose

Patients with persistently controlled atopic dermatitis who had their doses reduced were able to maintain their low disease activity.